Aytu BioScience
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $15,135 | $18,452 | $16,221 | $16,574 |
Gross Profit | 10,254 | 12,806 | 10,786 | 11,985 |
EBITDA | -7,623 | 6,035 | 2,800 | 3,919 |
EBIT | -8,917 | 4,718 | 1,461 | 2,492 |
Net Income | -19,818 | 3,994 | 788 | 1,474 |
Net Change In Cash | 15,135 | 18,452 | 16,221 | 16,574 |
Free Cash Flow | -214 | -6,524 | 2,899 | -1,326 |
Cash | 30,952 | 18,173 | 20,398 | 20,108 |
Basic Shares | 6,791 | 8,204 | 8,485 | 9,099 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $66,382 | $81,002 | $107,399 | $96,669 |
Gross Profit | 45,831 | 49,374 | 66,632 | 46,439 |
EBITDA | -7,827 | -1,012 | -3,273 | -98,743 |
EBIT | -13,204 | -9,284 | -12,088 | -108,889 |
Net Income | -13,562 | -15,844 | -17,051 | -108,780 |
Net Change In Cash | 66,382 | 81,002 | 107,399 | 96,669 |
Free Cash Flow | -2,165 | -1,388 | -5,129 | -28,823 |
Cash | 30,952 | 20,006 | 22,985 | 19,360 |
Basic Shares | 6,279 | 5,537 | 3,339 | 1,470 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$2.93 |
2025-03-31 | $0.21 |
2024-12-31 | $0.13 |
2024-09-30 | -$0.15 |
